BNTC - CIK 0001808898
Benitec Biopharma Inc. trades as BNTC. In its fiscal 2021 annual report the company posted revenue of $59.00K, down 42.2% from the prior year and net income of -$37.92M. This page tracks Benitec Biopharma Inc. through 309 SEC filings, with financial statements and metrics updated as new reports are filed.
Net profit margin compressed from 21.4% to -23528.8% over the same period - every figure below comes from the company's audited annual filings.
| Filing | Type | Filed |
|---|---|---|
| Quarterly report | 10-Q | 2026-05-14 |
| Major company event | 8-K | 2026-05-14 |
| Annual report (amended) | 10-K/A | 2026-03-20 |
| Major company event | 8-K | 2026-02-12 |
| Quarterly report | 10-Q | 2026-02-12 |
| 424B3 | - | 2026-02-11 |
| EFFECT | - | 2026-02-10 |
| Company correspondence | CORRESP | 2026-02-06 |
The largest companies sharing Benitec Biopharma Inc.'s SEC industry classification (pharmaceutical preparations).
Benitec Biopharma Inc. reported revenue of $59.00K for fiscal year 2021, a decrease of 42.2% year over year.
In its latest fiscal year Benitec Biopharma Inc. reported a net loss of $37.92M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.